Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

19 trials with published results (37%)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

5.8%

3 terminated out of 52 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

40%

21 trials in Phase 3/4

Results Transparency

58%

19 of 33 completed with results

Key Signals

19 with results92% success

Data Visualizations

Phase Distribution

36Total
Not Applicable (8)
P 1 (3)
P 2 (4)
P 3 (12)
P 4 (9)

Trial Status

Completed33
Recruiting7
Unknown5
Terminated3
Not Yet Recruiting2
Suspended1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 33 completed trials

Clinical Trials (52)

Showing 20 of 20 trials
NCT07285863Phase 4RecruitingPrimary

A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects

NCT06052293Phase 1CompletedPrimary

Phase 1 Study to Assess Safety and Efficacy of ANG003

NCT07418593Phase 4Recruiting

Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis

NCT05710315Not ApplicableRecruiting

Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure

NCT04690738SuspendedPrimary

Role of Pancreatic Exocrine Secretion in Weight Gain After Pancreas Transplantation

NCT06477159Phase 4RecruitingPrimary

Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency

NCT06756503Not Yet RecruitingPrimary

Exocrine Pancreatic Insufficiency and Functional Dyspepsia

NCT06757348Not Yet RecruitingPrimary

Fatty Liver and Pancreatic Steatosis

NCT06999954Recruiting

Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform

NCT04548778CompletedPrimary

BÜHLMANN FPELA in the Diagnosis of Exocrine Pancreatic Insufficiency

NCT05082051Phase 1CompletedPrimary

Oral CDX-7108 in Healthy Adults and EPI Subjects

NCT05719311Phase 2CompletedPrimary

Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis

NCT02175459Recruiting

Investigating Predictive Factors of Diabetes Occurence After Duodenalpancreatectomy

NCT06278272Completed

AI Evaluation of Pancreatic Exocrine Insufficiency in CP Patients

NCT05385211Completed

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 Diabetes

NCT02563080CompletedPrimary

Pancreatic Exocrine Insufficiency in Acute Pancreatitis

NCT05480241Not ApplicableUnknown

Exocrine Pancreatic Insufficiency After Acute Pancreatitis and Pancreatic Enzyme Replacement Therapy

NCT05450627UnknownPrimary

Registry of Pancreatic Exocrine Insufficiency.

NCT01427725CompletedPrimary

Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency

NCT01427712Completed

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Scroll to load more

Research Network

Activity Timeline